Looking for:
Cefdinir for Oral Suspension |
Dosage for omnicef suspension
Dosage for omnicef suspension
Dosage for omnicef suspension. Cefdinir for Oral Suspension
Drospirenone; Ethinyl Estradiol; Levomefolate: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics. Elagolix; Estradiol; Norethindrone acetate: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics.
Estradiol; Levonorgestrel: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics. Estradiol; Norethindrone: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics.
Estradiol; Norgestimate: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics.
Ethinyl Estradiol: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics. Ethinyl Estradiol; Levonorgestrel; Folic Acid; Levomefolate: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics.
Ethinyl Estradiol; Norelgestromin: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics. Ethinyl Estradiol; Norethindrone Acetate: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics.
Ethinyl Estradiol; Norgestrel: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics. Ethynodiol Diacetate; Ethinyl Estradiol: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics.
Etonogestrel; Ethinyl Estradiol: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics. Ferric Maltol: Moderate Administer cefdinir at least 2 hours before or 2 hours after iron supplements.
Iron Salts: Moderate Administer cefdinir at least 2 hours before or 2 hours after iron supplements. Iron: Moderate Administer cefdinir at least 2 hours before or 2 hours after iron supplements. Lanthanum Carbonate: Moderate To limit absorption problems, cefdinir should not be taken within 2 hours of dosing with lanthanum carbonate.
Oral drugs known to interact with cationic antacids, like cefdinir, may be bound by lanthanum carbonate. Separate the times of administration appropriately. Monitor the patient to ensure the appropriate response to cefdinir is obtained. Leuprolide; Norethindrone: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics. Levonorgestrel: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics.
Levonorgestrel; Ethinyl Estradiol: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics. Levonorgestrel; Ethinyl Estradiol; Ferrous Bisglycinate: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics.
Loop diuretics: Minor Nephrotoxicity associated with cephalosporins may be potentiated by concomitant therapy with loop diuretics. Clinicians should be aware that this may occur even in patients with minor or transient renal impairment. Magnesium Salicylate: Moderate Administer cefdinir at least 2 hours before or 2 hours after magnesium salicylate. Magnesium Salts: Moderate Administer cefdinir at least 2 hours before or 2 hours after magnesium chloride.
Moderate Administer cefdinir at least 2 hours before or 2 hours after magnesium gluconate. Moderate Administer cefdinir at least 2 hours before or 2 hours after magnesium sulfate. Mestranol; Norethindrone: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics. Norethindrone Acetate; Ethinyl Estradiol; Ferrous fumarate: Moderate Administer cefdinir at least 2 hours before or 2 hours after iron supplements.
Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics. Norethindrone: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics.
Norethindrone; Ethinyl Estradiol: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics. Norethindrone; Ethinyl Estradiol; Ferrous fumarate: Moderate Administer cefdinir at least 2 hours before or 2 hours after iron supplements. Norgestimate; Ethinyl Estradiol: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics.
Norgestrel: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics. Oral Contraceptives: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics.
Polysaccharide-Iron Complex: Moderate Administer cefdinir at least 2 hours before or 2 hours after iron supplements. Relugolix; Estradiol; Norethindrone acetate: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics.
Segesterone Acetate; Ethinyl Estradiol: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics. Sodium Ferric Gluconate Complex; ferric pyrophosphate citrate: Moderate Administer cefdinir at least 2 hours before or 2 hours after iron supplements. Sodium picosulfate; Magnesium oxide; Anhydrous citric acid: Major Prior or concomitant use of antibiotics with sodium picosulfate; magnesium oxide; anhydrous citric acid may reduce efficacy of the bowel preparation as conversion of sodium picosulfate to its active metabolite bis- p-hydroxy-phenyl -pyridylmethane BHPM is mediated by colonic bacteria.
If possible, avoid coadministration. Certain antibiotics i. Therefore, these antibiotics should be taken at least 2 hours before and not less than 6 hours after the administration of sodium picosulfate; magnesium oxide; anhydrous citric acid solution. Sodium Sulfate; Magnesium Sulfate; Potassium Chloride: Moderate Administer cefdinir at least 2 hours before or 2 hours after magnesium sulfate. Warfarin: Moderate The concomitant use of warfarin with many classes of antibiotics, including cephalosporins, may increase the INR thereby potentiating the risk for bleeding.
Inhibition of vitamin K synthesis due to alterations in the intestinal flora may be a mechanism; however, concurrent infection is also a potential risk factor for elevated INR. Additionally, certain cephalosporins cefotetan, cefoperazone, cefamandole are associated with prolongation of the prothrombin time due to the methylthiotetrazole MTT side chain at the R2 position, which disturbs the synthesis of vitamin K-dependent clotting factors in the liver.
Monitor patients for signs and symptoms of bleeding. Additionally, increased monitoring of the INR, especially during initiation and upon discontinuation of the antibiotic, may be necessary. Cefdinir is a beta-lactam antibiotic like the penicillins and is mainly bactericidal. Cefdinir inhibits the third and final stage of bacterial cell wall synthesis by preferentially binding to specific penicillin-binding proteins PBPs that are located inside the bacterial cell wall.
Penicillin-binding proteins are responsible for several steps in the synthesis of the cell wall and are found in quantities of several hundred to several thousand molecules per bacterial cell.
Penicillin-binding proteins vary among different bacterial species. Thus, the intrinsic activity of cefdinir as well as the other cephalosporins and penicillins against a particular organism depends on their ability to gain access to and bind with the necessary PBP.
Like all beta-lactam antibiotics, the ability of cefdinir to interfere with PBP-mediated cell wall synthesis ultimately leads to cell lysis.
Lysis is mediated by bacterial cell wall autolytic enzymes i. Take this medicine only as directed by your doctor. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered.
Shake the oral liquid well before each use. Measure the medicine with a marked measuring spoon, oral syringe, or medicine cup. The average household teaspoon may not hold the right amount of liquid. If you are taking aluminum or magnesium-containing antacids, iron supplements, or multivitamins, do not take them at the same time that you take this medicine.
It is best to take these medicines at least 2 hours before or after taking cefdinir. These medicines may keep cefdinir from working properly. Keep using this medicine for the full treatment time, even if you feel better after the first few doses. Your infection may not clear up if you stop using the medicine too soon. The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label.
The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so. Once-daily dosing has not been studied in skin infections; therefore, cefdinir for oral suspension should be administered twice daily in this infection.
Cefdinir for oral suspension may be administered without regard to meals. Creatinine clearance is difficult to measure in outpatients. However, the following formula may be used to estimate creatinine clearance CL cr in adult patients. For estimates to be valid, serum creatinine levels should reflect steady-state levels of renal function. Tap bottle to loosen powder, then add water in 2 portions. Shake well after each aliquot. The container should be kept tightly closed, and the suspension should be shaken well before each administration.
The suspension may be used for 10 days, after which any unused portion must be discarded. The reconstituted suspensions have a cream color and strawberry flavor. Once reconstituted, the oral suspension can be stored at controlled room temperature for 10 days.
In a controlled, double-blind study in adults and adolescents conducted in the U. Using strict evaluability and clinical response criteria 6 to 14 days post-therapy, the following clinical cure rates, presumptive microbiologic eradication rates, and statistical outcomes were obtained:.
In four controlled studies conducted in the United States, cefdinir was compared with 10 days of penicillin in adult, adolescent, and pediatric patients.
Rx Only To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefdinir and other antibacterial drugs, cefdinir should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. Multiple Dosing Cefdinir does not accumulate in plasma following once- or twice-daily administration to subjects with normal renal function.
Distribution The mean volume of distribution Vd area of cefdinir in adult subjects is 0. Skin Blister In adult subjects, median range maximal blister fluid cefdinir concentrations of 0. Tonsil Tissue In adult patients undergoing elective tonsillectomy, respective median tonsil tissue cefdinir concentrations 4 hours after administration of single and mg doses were 0. Lung Tissue In adult patients undergoing diagnostic bronchoscopy, respective median bronchial mucosa cefdinir concentrations 4 hours after administration of single and mg doses were 0.
CSF Data on cefdinir penetration into human cerebrospinal fluid are not available. Metabolism and Excretion Cefdinir is not appreciably metabolized.
Special Populations Patients with Renal Insufficiency Cefdinir pharmacokinetics were investigated in 21 adult subjects with varying degrees of renal function. Hemodialysis Cefdinir pharmacokinetics were studied in 8 adult subjects undergoing hemodialysis.
Hepatic Disease Because cefdinir is predominantly renally eliminated and not appreciably metabolized, studies in patients with hepatic impairment were not conducted. Geriatric Patients The effect of age on cefdinir pharmacokinetics after a single mg dose was evaluated in 32 subjects 19 to 91 years of age. Microbiology Mechanism of Action As with other cephalosporins, bactericidal activity of cefdinir results from inhibition of cell wall synthesis.
Mechanism of Resistance Resistance to cefdinir is primarily through hydrolysis by some beta-lactamases, alteration of penicillin-binding proteins PBPs and decreased permeability. Gram-Positive Bacteria Staphylococcus aureus methicillin-susceptible strains only Streptococcus pneumoniae penicillin-susceptible strains only Streptococcus pyogenes Gram-Negative Bacteria Haemophilus influenzae Haemophilus parainfluenzae Moraxella catarrhalis The following in vitro data are available, but their clinical significance is unknown.
Acute Exacerbations of Chronic Bronchitis Caused by Haemophilus influenzae including beta-lactamase producing strains , Haemophilus parainfluenzae including beta-lactamase producing strains , Streptococcus pneumoniae penicillin-susceptible strains only , and Moraxella catarrhalis including beta-lactamase producing strains.
Acute Maxillary Sinusitis Caused by Haemophilus influenzae including beta-lactamase producing strains , Streptococcus pneumoniae penicillin-susceptible strains only , and Moraxella catarrhalis including beta-lactamase producing strains. Uncomplicated Skin and Skin Structure Infections Caused by Staphylococcus aureus including beta-lactamase producing strains and Streptococcus pyogenes.
Pediatric Patients Acute Bacterial Otitis Media Caused by Haemophilus influenzae including beta-lactamase producing strains , Streptococcus pneumoniae penicillin-susceptible strains only , and Moraxella catarrhalis including beta-lactamase producing strains. Information for Patients Patients should be counseled that antibacterial drugs including cefdinir should only be used to treat bacterial infections. Carcinogenesis, Mutagenesis, Impairment of Fertility The carcinogenic potential of cefdinir has not been evaluated.
Labor and Delivery Cefdinir has not been studied for use during labor and delivery. Nursing Mothers Following administration of single mg doses, cefdinir was not detected in human breast milk. Pediatric Use Safety and efficacy in neonates and infants less than 6 months of age have not been established. Geriatric Use Efficacy is comparable in geriatric patients and younger adults. Cephalosporin Class Adverse Events The following adverse events and altered laboratory tests have been reported for cephalosporin-class antibiotics in general: Allergic reactions, anaphylaxis, Stevens-Johnson syndrome, erythema multiforme, toxic epidermal necrolysis, renal dysfunction, toxic nephropathy, hepatic dysfunction including cholestasis, aplastic anemia, hemolytic anemia, hemorrhage, false-positive test for urinary glucose, neutropenia, pancytopenia, and agranulocytosis.
Patients on Hemodialysis Hemodialysis removes cefdinir from the body. Prediction of creatinine clearance from serum creatinine. Nephron ; A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics ; A simple estimate of glomerular filtration rate in full-term infants during the first year of life.
J Pediatrics ; Acute Bacterial Otitis Media. Acute Maxillary Sinusitis. Uncomplicated Skin and Skin Structure Infections. Clinical Cure Rates. Cefdinir equivalent to control.
Cefdinir not equivalent to control. Eradication of S. Cefdinir superior to control.
Send the page " " to a friend, relative, colleague or yourself. We do not record any personal information entered above. Oral extended-spectrum, semisynthetic, third generation cephalosporin. It is not active against methicillin-resistant staphylococci or Pseudomonas aeruginosa. Cefdinir is used for skin infections and a variety of upper respiratory infections. Guidelines recommend cefdinir as an alternative to high-dose amoxicillin or high-dose amoxicillin; clavulanate in penicillin allergic patients.
Third-generation oral cephalosporins, such as cefdinir, are not recommended by the Infectious Disease Society of America IDSA for empiric monotherapy of acute bacterial sinusitis due to variable rates of S. Guidelines recommend cefdinir as an alternative to amoxicillin or amoxicillin; clavulanate for infections due to H. Guidelines do not recommend cefdinir for Group A Streptococcal pharyngitis to prevent rheumatic fever.
Guidelines do not recommend cefdinir Group A Streptococcal pharyngitis to prevent rheumatic fever. A 3- to 7-day course of cefidinir may be an alternative in patients with uncomplicated cystitis when other recommended agents cannot be used.
Cefdinir has been shown to be statistically equivalent to cefaclor for microbiologic response rates and clinical cure rates in adults with uncomplicated urinary tract infection UTI. A treatment course of 7 to 14 days is recommended by the American Academy of Pediatrics AAP for the treatment of initial UTI in febrile infants and young children 2 to 24 months of age.
Shorter courses 2 to 4 days may be used in older children with uncomplicated cystitis. In a retrospective in vitro antimicrobial susceptibility study in children, This rate was comparable or superior to rates for other antibiotics i. Intermittent hemodialysis Hemodialysis removes cefdinir from the body. If antacids or iron supplements are necessary during cefdinir therapy, cefdinir should be given at least 2 hours before or after the antacid or iron supplement.
Iron-fortified infant formulas do not significantly alter the absorption of cefdinir. Cefdinir oral suspension may be administered without regard to meals. Shake well prior to each use. For accurate dosage, measure using a calibrated oral syringe, spoon or cup.
Suspension Reconstitution: Tap the bottle to loosen the powder. The water will be added in 2 portions; shake well after each aliquot. See manufacturer's specific instructions regarding reconstitution volumes needed. After mixing, the suspension can be stored at controlled room temperature. The container should be kept tightly closed when not in use. The suspension may be used for 10 days, after which any unused portion must be discarded. Omnicef: - Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F - Store in original container.
A false-positive reaction for glucose in the urine has been observed in patients receiving cephalosporins, such as cefdinir, and using Benedict's solution, Fehling's solution, or Clinitest tablets for urine glucose testing. However, this reaction has not been observed with glucose oxidase tests e. Patients with diabetes mellitus who test their urine for glucose should use glucose tests based on enzymatic glucose oxidase reactions while on cefdinir treatment.
A positive direct Coombs test may develop in some patients. In hematologic studies or in transfusion cross-matching procedures when antiglobulin tests are performed on the minor side or in Coombs test of newborns whose mothers received cefdinir before delivery, clinicians should keep in mind that a positive Coombs test may be due to the drug.
Cefdinir does not treat viral infection e. Prescribing in the absence of a proven or strongly suspected bacterial infection or a prophylactic indication is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria antimicrobial resistance.
Patients should be told to complete the full course of treatment, even if they feel better earlier. Cefdinir is contraindicated in patients with a known history of cephalosporin hypersensitivity or cephamycin hypersensitivity.
Cefdinir should be used cautiously in patients with hypersensitivity to penicillin. The structural similarity between cefdinir and penicillin means cross-reactivity can occur. Penicillins can cause a variety of hypersensitivity reactions ranging from mild rash to fatal anaphylaxis. Patients who have experienced severe penicillin hypersensitivity should not receive cefdinir.
Cefdinir should be used with caution in patients who have had a delayed-type reaction to penicillin or related drugs. Serum sickness-like reactions have occurred following a second course of therapy.
Because hemodialysis removes cefdinir from the body, additional dosage adjustments are needed to ensure therapeutic effect if a patient receives dialysis.
Consider pseudomembranous colitis in patients presenting with diarrhea after antibacterial use. Careful medical history is necessary as pseudomembranous colitis has been reported to occur over 2 months after the administration of antibacterial agents.
Almost all antibacterial agents, including cefdinir, have been associated with pseudomembranous colitis or C. Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of C. All cephalosporins, including cefdinir, can rarely cause hypoprothrombinemia and have the potential to cause bleeding.
Cephalosporins, which contain the methylthiotetrazole MTT side chain e. Cephalosporins should be used cautiously in patients with a preexisting coagulopathy e.
In patients with diabetes mellitus, it should be noted that cefdinir oral suspension contains sucrose 1. Safety and efficacy of cefdinir in neonates and infants less than 6 months of age have not been established. Cefdinir is classified in FDA pregnancy risk category B. Animal data show that there are no teratogenic effects of cefdinir in rats.
There are, however, no adequate and well-controlled studies in pregnant women, Because animal reproduction studies are not always predictive of human response, cefdinir should be used during pregnancy only if clearly needed.
Cefdinir may be administered to breast-feeding women. Cefdinir was not detected in human breast milk following single mg oral doses. Dose adjustment of cefdinir is not necessary in the geriatric patient unless renal function is markedly compromised. Clinical trial data and clinical experience suggests similar efficacy toin geriatric and younger adult patients. According to OBRA, use of antibiotics should be limited to confirmed or suspected bacterial infections.
Antibiotics are non-selective and may result in the eradication of beneficial microorganisms while promoting the emergence of undesired ones, causing secondary infections such as oral thrush, colitis, or vaginitis. Any antibiotic may cause diarrhea, nausea, vomiting, anorexia, and hypersensitivity reactions.
Acetaminophen; Caffeine; Magnesium Salicylate; Phenyltoloxamine: Moderate Administer cefdinir at least 2 hours before or 2 hours after magnesium salicylate. Cefdinir absorption may be reduced.
Antacids: Moderate Antacids containing magnesium or aluminum can interfere with the absorption of cefdinir. If aluminum or magnesium containing antacids are required during cefdinir therapy, cefdinir should be taken at least 2 hours before or after the antacid. Choline Salicylate; Magnesium Salicylate: Moderate Administer cefdinir at least 2 hours before or 2 hours after magnesium salicylate. Desogestrel; Ethinyl Estradiol: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics.
It was previously thought that antibiotics may decrease the effectiveness of OCs containing estrogens due to stimulation of metabolism or a reduction in enterohepatic circulation via changes in GI flora. One retrospective study reviewed the literature to determine the effects of oral antibiotics on the pharmacokinetics of contraceptive estrogens and progestins, and also examined clinical studies in which the incidence of pregnancy with OCs and antibiotics was reported.
It was concluded that the antibiotics ampicillin, ciprofloxacin, clarithromycin, doxycycline, metronidazole, ofloxacin, roxithromycin, temafloxacin, and tetracycline did not alter plasma concentrations of OCs. Antituberculous drugs e. Based on the study results, these authors recommended that back-up contraception may not be necessary if OCs are used reliably during oral antibiotic use.
Another review concurred with these data, but noted that individual patients have been identified who experienced significant decreases in plasma concentrations of combined OC components and who appeared to ovulate; the agents most often associated with these changes were rifampin, tetracyclines, and penicillin derivatives. These authors concluded that because females most at risk for OC failure or noncompliance may not be easily identified and the true incidence of such events may be under-reported, and given the serious consequence of unwanted pregnancy, that recommending an additional method of contraception during short-term antibiotic use may be justified.
During long-term antibiotic administration, the risk for drug interaction with OCs is less clear, but alternative or additional contraception may be advisable in selected circumstances. Data regarding progestin-only contraceptives or for newer combined contraceptive deliveries e. Dienogest; Estradiol valerate: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics.
Drospirenone: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics. Drospirenone; Estetrol: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics. Drospirenone; Estradiol: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics.
Drospirenone; Ethinyl Estradiol: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics. Drospirenone; Ethinyl Estradiol; Levomefolate: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics.
Elagolix; Estradiol; Norethindrone acetate: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics. Estradiol; Levonorgestrel: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics.
Estradiol; Norethindrone: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics. Estradiol; Norgestimate: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics. Ethinyl Estradiol: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics.
Ethinyl Estradiol; Levonorgestrel; Folic Acid; Levomefolate: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics. Ethinyl Estradiol; Norelgestromin: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics. Ethinyl Estradiol; Norethindrone Acetate: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics.
Ethinyl Estradiol; Norgestrel: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics. Ethynodiol Diacetate; Ethinyl Estradiol: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics. Etonogestrel; Ethinyl Estradiol: Moderate It would be prudent to recommend alternative or additional contraception when oral contraceptives OCs are used in conjunction with antibiotics.
Ferric Maltol: Moderate Administer cefdinir at least 2 hours before or 2 hours after iron supplements. Iron Salts: Moderate Administer cefdinir at least 2 hours before or 2 hours after iron supplements. Iron: Moderate Administer cefdinir at least 2 hours before or 2 hours after iron supplements.
Once-daily dosing has not been studied in skin infections; therefore, OMNICEF for Oral Suspension should be administered twice daily in this infection. Infants and children 6 months. HOW TO USE: Take this medication by mouth with or without food as directed by your doctor, usually once a day or twice a day (every 12 hours). Shake the bottle. Use caps. ≥13yrs: Pneumonia, skin and skin structure: mg every 12hrs for 10 days. Bronchitis, pharyngitis/tonsillitis: mg every 12hrs for 5–10 days. Once-daily dosing has not been studied in skin infections; therefore, OMNICEF for Oral Suspension should be administered twice daily in this infection. Antacids: Moderate Antacids containing magnesium or aluminum can interfere with the absorption of cefdinir. Cefdinir is stable in the presence of some, but not all, beta-lactamase enzymes. The water will be added in 2 portions; shake well after each aliquot. If we combine this information with your protected health information, we will treat all of that information as protected health information and will only use or disclose that information as set forth in our notice of privacy practices.Drug information provided by: IBM Micromedex. Take this medicine only as directed by your doctor. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered.
Shake the oral liquid well before each use. Measure the medicine with a marked measuring spoon, oral syringe, or medicine cup. The average household teaspoon may not hold the right amount of liquid. If you are taking aluminum or magnesium-containing antacids, iron supplements, or multivitamins, do not take them at the same time that you take this medicine. It is best to take these medicines at least 2 hours before or after taking cefdinir.
These medicines may keep cefdinir from working properly. Keep using this medicine for the full treatment time, even if you feel better after the first few doses. Your infection may not clear up if you stop using the medicine too soon. The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine.
If your dose is different, do not change it unless your doctor tells you to do so. The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine. If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule.
Do not double doses. Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing. There is a problem with information submitted for this request. Sign up for free, and stay up to date on research advancements, health tips and current health topics, like COVID, plus expertise on managing health.
To provide you with the most relevant and helpful information, and understand which information is beneficial, we may combine your email and website usage information with other information we have about you. If you are a Mayo Clinic patient, this could include protected health information. If we combine this information with your protected health information, we will treat all of that information as protected health information and will only use or disclose that information as set forth in our notice of privacy practices.
You may opt-out of email communications at any time by clicking on the unsubscribe link in the e-mail. You'll soon start receiving the latest Mayo Clinic health information you requested in your inbox.
All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes. Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press. Any use of this site constitutes your agreement to the Terms and Conditions and Privacy Policy linked below. This site complies with the HONcode standard for trustworthy health information: verify here. This content does not have an English version. This content does not have an Arabic version. See more conditions. Drugs and Supplements Cefdinir Oral Route. Products and services. Thank you for subscribing!
Sorry something went wrong with your subscription Please, try again in a couple of minutes Retry.
Comments
Post a Comment